MDxhealth Receives Nasdaq Noncompliance Notice
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Mdxhealth Receives Nasdaq Noncompliance Notice, Gets Time Through Dec. 28 To Regain Compliance
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
MDXHealth Announces Peer-Reviewed Publication Of The Oxford GPS-ProMPT Study In the Journal 'European Urology Oncology'
Lake Street Maintains Buy on MDxHealth, Lowers Price Target to $5
TD Cowen Maintains Buy on MDxHealth, Lowers Price Target to $1.5
BTIG Maintains Buy on MDxHealth, Lowers Price Target to $4
MDxHealth SA (MDXH) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Focus Amid ...
MDxHealth (MDXH) Q1 2026 Earnings Transcript
MDxHealth Q1 Earnings Call Highlights
MDxHealth SA (MDXH) Q1 2026 Earnings Call Transcript
MDxHealth Reports Q1 2026 Results: Full Earnings Call Transcript
Mdxhealth Reports Q1-2026 Results
MDxHealth Lowers FY2026 Sales Guidance from $137.000M-$140.000M to $110.000M-$115.000M vs $135.912M Est
MDxHealth Q1 EPS $(0.17) Misses $(0.12) Estimate, Sales $27.386M Miss $30.620M Estimate
TruBridge (TBRG) Surpasses Q1 Earnings Estimates
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
Tempus AI (TEM) Reports Q1 Loss, Beats Revenue Estimates
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.